Tang Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-800,000	Closed	-$6.24M	–	55
2025 Q4	$6.24M	Hold	800,000	–	–	0.31%	53
2025 Q3	$6.07M	Hold	800,000	–	–	0.23%	89
2025 Q2	$7.17M	Hold	800,000	–	–	0.36%	68
2025 Q1	$6M	Hold	800,000	–	–	0.33%	69
2024 Q4	$6.02M	Hold	800,000	–	–	0.4%	63
2024 Q3	$6.08M	Hold	800,000	–	–	0.43%	64
2024 Q2	$4.94M	Hold	800,000	–	–	0.5%	58
2024 Q1	$4.06M	Hold	800,000	–	–	0.42%	64
2023 Q4	$4.79M	Sell	800,000 -1,000,000	-56%	-$5.79M	0.44%	59
2023 Q3	$12.7M	Sell	1,800,000 -650,000	-27%	-$4.67M	1.8%	16
2023 Q2	$17.2M	Buy	2,450,000 +850,000	+53%	+$6.82M	2.54%	12
2023 Q1	$13.3M	Buy	1,600,000 +150,000	+10%	+$1.44M	1.99%	16
2022 Q4	$16.6M	Buy	1,450,000 +250,000	+21%	+$3.12M	2.42%	13
2022 Q3	$15.1M	Hold	1,200,000	–	–	1.85%	17
2022 Q2	$12.7M	Buy	+1,200,000	New	+$12.4M	1.93%	18
2016 Q3	–	Sell	-430,000	Closed	-$1.22M	–	9
2016 Q2	$1.22M	Hold	430,000	–	–	0.54%	9
2016 Q1	$1.22M	Buy	+430,000	New	+$1.91M	0.55%	11